We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.07B
1-Year Est. Return 78.71%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+78.71%
3 Year Est. Return
+323.31%
5 Year Est. Return
+574.14%
10 Year Est. Return
+3,824.29%
AUM
$2.8B
AUM Growth
+$635M
Cap. Flow
+$218M
Cap. Flow %
7.79%
Top 10 Hldgs %
49.77%
Holding
313
New
122
Increased
18
Reduced
66
Closed
70

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$183M
2
ESGR
Enstar Group
ESGR
+$157M
3
BPMC
Blueprint Medicines
BPMC
+$138M
4
SKX
Skechers
SKX
+$137M
5
DNB
Dun & Bradstreet
DNB
+$129M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$208M
2
PDCO
Patterson Companies, Inc.
PDCO
+$149M
3
ATSG
Air Transport Services Group
ATSG
+$95M
4
PLYA
Playa Hotels & Resorts
PLYA
+$93.6M
5
SWI
SolarWinds Corporation Common Stock
SWI
+$90.9M

Sector Composition

Rank Sector Weight
1 Financials 32.71%
2 Miscellaneous 18.12%
3 Healthcare 14.93%
4 Consumer Discretionary 10.35%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTW.U
226
DELISTED
EQV Ventures Acquisition Corp Units
FTW.U
$1K ﹤0.01%
+100
New +$1.03K
BACQU
227
DELISTED
Inflection Point Acquisition Corp IV Unit
BACQU
$1K ﹤0.01%
100
– –
ANSCU
228
DELISTED
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
$0 ﹤0.01%
5
– –
BAYA
229
DELISTED
Bayview Acquisition Corp
BAYA
– –
-192,491
Closed -$2.1M
BUJA
230
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
– –
-333,999
Closed -$3.8M
CCRN
231
DELISTED
Cross Country Healthcare
CCRN
– –
-264,387
Closed -$3.94M
CHRS icon
232
Coherus Oncology
CHRS
$218M
– –
-1
Closed –
CKPT
233
DELISTED
Checkpoint Therapeutics
CKPT
– –
-3,165,000
Closed -$12.8M
DDOG icon
234
Datadog
DDOG
$74.7B
– –
-32,300
Closed -$3.2M
DESP
235
DELISTED
Despegar.com
DESP
– –
-895,597
Closed -$16.8M
DESP
236
PUT
DELISTED
Despegar.com
DESP
– –
-252
Closed -$65K
HEES
237
DELISTED
H&E Equipment Services
HEES
– –
-430,177
Closed -$40.8M
HYAC.WS
238
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
– –
-99,860
Closed -$21K
IVCA
239
DELISTED
Investcorp India Acquisition Corp
IVCA
– –
-196,407
Closed -$2.37M
JWN
240
DELISTED
Nordstrom
JWN
– –
-726,188
Closed -$17.8M
NETDU
241
DELISTED
Nabors Energy Transition Corp II Unit
NETDU
$0 ﹤0.01%
1
– –
NTNX icon
242
Nutanix
NTNX
$18.2B
– –
-15,600
Closed -$1.09M
PLYA
243
DELISTED
Playa Hotels & Resorts
PLYA
– –
-7,024,807
Closed -$93.6M
RDUS
244
CALL
DELISTED
Radius Recycling
RDUS
– –
-1,000
Closed -$7K
RENE
245
DELISTED
Cartesian Growth Corp II
RENE
– –
-390,098
Closed -$4.63M
SSTK icon
246
CALL
Shutterstock
SSTK
$195M
– –
-124
Closed -$15K
SSTK icon
247
Shutterstock
SSTK
$195M
– –
-135,000
Closed -$2.52M
TFIN icon
248
PUT
Triumph Financial Inc
TFIN
$1.65B
– –
-307
Closed -$2K
TSVT
249
DELISTED
2seventy bio
TSVT
– –
-1,328,166
Closed -$6.56M
WBA
250
DELISTED
Walgreens Boots Alliance
WBA
– –
-5,071,180
Closed -$56.6M
8 9
10
11 12

Similar funds

PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Glazer Capital LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Glazer Capital LLC held 313 positions worth $2.8B, up 29% from $2.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glazer Capital LLC deployed $218M of net new capital in Q2 2025, opening 122 new positions and adding to 18 existing holdings. Its largest new stake was SpringWorks Therapeutics: 4,107,199 shares worth $193M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $78.8M trimmed.

  • Glazer Capital LLC's largest Q2 2025 buy was SpringWorks Therapeutics: 4,107,199 shares worth $193M.
  • Glazer Capital LLC added most to Enstar Group in Q2 2025, an estimated $157M increase.
  • Glazer Capital LLC's biggest Q2 2025 reduction was Kellanova, cutting an estimated $78.8M.
  • Glazer Capital LLC fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $208M.
  • Glazer Capital LLC's ten largest holdings make up 50% of its $2.8B portfolio in Q2 2025.
  • Glazer Capital LLC opened 122 new positions and closed 70 in Q2 2025.
  • Glazer Capital LLC's portfolio value rose 29% quarter-over-quarter to $2.8B.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.